{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T08:42:15Z","timestamp":1789461735304,"version":"build-2803163510"},"reference-count":57,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2023,6,1]]},"abstract":"<jats:sec id=\"ab-hoi230017-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Primary prevention of atherosclerotic cardiovascular disease (ASCVD) relies on risk stratification. Genome-wide polygenic risk scores (PRSs) are proposed to improve ASCVD risk estimation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-hoi230017-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine whether genome-wide PRSs for coronary artery disease (CAD) and acute ischemic stroke improve ASCVD risk estimation with traditional clinical risk factors in an ancestrally diverse midlife population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-hoi230017-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This was a prognostic analysis of incident events in a retrospectively defined longitudinal cohort conducted from January 1, 2011, to December 31, 2018. Included in the study were adults free of ASCVD and statin naive at baseline from the Million Veteran Program (MVP), a mega biobank with genetic, survey, and electronic health record data from a large US health care system. Data were analyzed from March 15, 2021, to January 5, 2023.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-hoi230017-7\">\n                    <jats:title>Exposures<\/jats:title>\n                    <jats:p>PRSs for CAD and ischemic stroke derived from cohorts of largely European descent and risk factors, including age, sex, systolic blood pressure, total cholesterol, high-density lipoprotein (HDL) cholesterol, smoking, and diabetes status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-hoi230017-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Incident nonfatal myocardial infarction (MI), ischemic stroke, ASCVD death, and composite ASCVD events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-hoi230017-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 79\u202f151 participants (mean [SD] age, 57.8 [13.7] years; 68\u202f503 male [86.5%]) were included in the study. The cohort included participants from the following harmonized genetic ancestry and race and ethnicity categories: 18\u202f505 non-Hispanic Black (23.4%), 6785 Hispanic (8.6%), and 53\u202f861 non-Hispanic White (68.0%) with a median (5th-95th percentile) follow-up of 4.3 (0.7-6.9) years. From 2011 to 2018, 3186 MIs (4.0%), 1933 ischemic strokes (2.4%), 867 ASCVD deaths (1.1%), and 5485 composite ASCVD events (6.9%) were observed. CAD PRS was associated with incident MI in non-Hispanic Black (hazard ratio [HR], 1.10; 95% CI, 1.02-1.19), Hispanic  (HR, 1.26; 95% CI, 1.09-1.46), and non-Hispanic White (HR, 1.23; 95% CI, 1.18-1.29) participants. Stroke PRS was associated with incident stroke in non-Hispanic White participants (HR, 1.15; 95% CI, 1.08-1.21). A combined CAD plus stroke PRS was associated with ASCVD deaths among non-Hispanic Black (HR, 1.19; 95% CI, 1.03-1.17) and non-Hispanic (HR, 1.11; 95% CI, 1.03-1.21) participants. The combined PRS was also associated with composite ASCVD across all ancestry groups but greater among non-Hispanic White (HR, 1.20; 95% CI, 1.16-1.24) than non-Hispanic Black (HR, 1.11; 95% CI, 1.05-1.17) and Hispanic (HR, 1.12; 95% CI, 1.00-1.25) participants. Net reclassification improvement from adding PRS to a traditional risk model was modest for the intermediate risk group for composite CVD among men (5-year risk &amp;amp;gt;3.75%, 0.38%; 95% CI, 0.07%-0.68%), among women, (6.79%; 95% CI, 3.01%-10.58%), for age older than 55 years (0.25%; 95% CI, 0.03%-0.47%), and for ages 40 to 55 years (1.61%; 95% CI, \u22120.07% to 3.30%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-hoi230017-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>Study results suggest that PRSs derived predominantly in European samples were statistically significantly associated with ASCVD in the multiancestry midlife and older-age MVP cohort. Overall, modest improvement in discrimination metrics were observed with addition of PRSs to traditional risk factors with greater magnitude in women and younger age groups.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamacardio.2023.0857","type":"journal-article","created":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T11:13:47Z","timestamp":1683112427000},"page":"564","source":"Crossref","is-referenced-by-count":44,"title":["Cardiovascular Disease Risk Assessment Using Traditional Risk Factors and Polygenic Risk Scores in the Million Veteran Program"],"prefix":"10.1001","volume":"8","author":[{"given":"Jason L.","family":"Vassy","sequence":"first","affiliation":[{"name":"Veterans Affairs Boston Healthcare System, Boston, Massachusetts"},{"name":"Department of Medicine, Brigham & Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel C.","family":"Posner","sequence":"additional","affiliation":[{"name":"Veterans Affairs Boston Healthcare System, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuk-Lam","family":"Ho","sequence":"additional","affiliation":[{"name":"Veterans Affairs Boston Healthcare System, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Gagnon","sequence":"additional","affiliation":[{"name":"Veterans Affairs Boston Healthcare System, Boston, Massachusetts"},{"name":"Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Galloway","sequence":"additional","affiliation":[{"name":"Veterans Affairs Boston Healthcare System, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidisha","family":"Tanukonda","sequence":"additional","affiliation":[{"name":"Veterans Affairs Atlanta Healthcare System, Decatur, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena C.","family":"Houghton","sequence":"additional","affiliation":[{"name":"Veterans Affairs Boston Healthcare System, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi K.","family":"Madduri","sequence":"additional","affiliation":[{"name":"Data Science and Learning Division, Argonne National Laboratory, Lemont, Illinois"},{"name":"University of Chicago Consortium for Advanced Science and Engineering, The University of Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin H.","family":"McMahon","sequence":"additional","affiliation":[{"name":"Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, New Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip S.","family":"Tsao","sequence":"additional","affiliation":[{"name":"Palo Alto VA Healthcare System, Palo Alto, California"},{"name":"Stanford Cardiovascular Institute, Stanford University, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott M.","family":"Damrauer","sequence":"additional","affiliation":[{"name":"Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania"},{"name":"Department of Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"O\u2019Donnell","sequence":"additional","affiliation":[{"name":"Veterans Affairs Boston Healthcare System, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Themistocles L.","family":"Assimes","sequence":"additional","affiliation":[{"name":"Palo Alto VA Healthcare System, Palo Alto, California"},{"name":"Division of Cardiovascular Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California"},{"name":"Stanford Cardiovascular Institute, Stanford University, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan P.","family":"Casas","sequence":"additional","affiliation":[{"name":"Veterans Affairs Boston Healthcare System, Boston, Massachusetts"},{"name":"Department of Medicine, Brigham & Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Michael","family":"Gaziano","sequence":"additional","affiliation":[{"name":"Veterans Affairs Boston Healthcare System, Boston, Massachusetts"},{"name":"Division of Aging, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Pencina","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan V.","family":"Sun","sequence":"additional","affiliation":[{"name":"Veterans Affairs Atlanta Healthcare System, Decatur, Georgia"},{"name":"Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Cho","sequence":"additional","affiliation":[{"name":"Veterans Affairs Boston Healthcare System, Boston, Massachusetts"},{"name":"Department of Medicine, Brigham & Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W.F.","family":"Wilson","sequence":"additional","affiliation":[{"name":"Veterans Affairs Atlanta Healthcare System, Decatur, Georgia"},{"name":"Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia"},{"name":"Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"8","key":"hoi230017r1","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1161\/CIR.0000000000001052","article-title":"Heart disease and stroke statistics-2022 update: a report from the American Heart Association.","volume":"145","author":"Tsao","year":"2022","journal-title":"Circulation"},{"issue":"25","key":"hoi230017r2","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1161\/01.cir.0000437741.48606.98","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines.","volume":"129","author":"Goff","year":"2014","journal-title":"Circulation"},{"issue":"14","key":"hoi230017r3","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1001\/jama.2014.2630","article-title":"Validation of the atherosclerotic cardiovascular disease pooled cohort risk equations.","volume":"311","author":"Muntner","year":"2014","journal-title":"JAMA"},{"key":"hoi230017r4","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.amjcard.2021.02.032","article-title":"Validation of an integrated risk tool, including polygenic risk score, for atherosclerotic cardiovascular disease in multiple ethnicities and ancestries.","volume":"148","author":"Weale","year":"2021","journal-title":"Am J Cardiol"},{"issue":"5","key":"hoi230017r5","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.ajhg.2020.04.002","article-title":"Predictive utility of polygenic risk scores for coronary heart disease in 3 major racial and ethnic groups.","volume":"106","author":"Dikilitas","year":"2020","journal-title":"Am J Hum Genet"},{"issue":"1","key":"hoi230017r6","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41746-022-00578-w","article-title":"Impact of polygenic risk communication: an observational mobile application-based coronary artery disease study.","volume":"5","author":"Muse","year":"2022","journal-title":"NPJ Digit Med"},{"issue":"5","key":"hoi230017r7","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1038\/s41591-022-01767-6","article-title":"Development of a clinical polygenic risk score assay and reporting workflow.","volume":"28","author":"Hao","year":"2022","journal-title":"Nat Med"},{"issue":"9","key":"hoi230017r9","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/s41588-018-0183-z","article-title":"Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations.","volume":"50","author":"Khera","year":"2018","journal-title":"Nat Genet"},{"issue":"1","key":"hoi230017r10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003498","article-title":"Polygenic risk scores in cardiovascular risk prediction: a cohort study and modelling analyses.","volume":"18","author":"Sun","year":"2021","journal-title":"PLoS Med"},{"issue":"8","key":"hoi230017r11","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1161\/CIR.0000000000001077","article-title":"Polygenic risk scores for cardiovascular disease: a scientific statement from the American Heart Association.","volume":"146","author":"O'Sullivan","year":"2022","journal-title":"Circulation"},{"issue":"7","key":"hoi230017r12","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1001\/jama.2019.21782","article-title":"Predictive accuracy of a polygenic risk score compared with a clinical risk score for incident coronary heart disease.","volume":"323","author":"Mosley","year":"2020","journal-title":"JAMA"},{"key":"hoi230017r13","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.jclinepi.2015.09.016","article-title":"Million Veteran Program: a mega-biobank to study genetic influences on health and disease.","volume":"70","author":"Gaziano","year":"2016","journal-title":"J Clin Epidemiol"},{"issue":"7","key":"hoi230017r14","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.8236","article-title":"Estimation of atherosclerotic cardiovascular disease risk among patients in the Veterans Affairs health care system.","volume":"3","author":"Vassy","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"4","key":"hoi230017r15","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.ajhg.2019.08.012","article-title":"Harmonizing genetic ancestry and self-identified race\/ethnicity in genome-wide association studies.","volume":"105","author":"Fang","year":"2019","journal-title":"Am J Hum Genet"},{"issue":"suppl 2","key":"hoi230017r16","doi-asserted-by":"publisher","first-page":"8954","DOI":"10.1073\/pnas.0914618107","article-title":"Colloquium paper: genome-wide patterns of population structure and admixture among Hispanic\/Latino populations.","volume":"107","author":"Bryc","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"hoi230017r17","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/NAQ.0000000000000118","article-title":"The Veterans Affairs\u2019s corporate data warehouse: uses and implications for nursing research and practice.","volume":"39","author":"Price","year":"2015","journal-title":"Nurs Adm Q"},{"issue":"4","key":"hoi230017r20","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.ajhg.2020.03.004","article-title":"Genotyping array design and data quality control in the Million Veteran Program.","volume":"106","author":"Hunter-Zinck","year":"2020","journal-title":"Am J Hum Genet"},{"issue":"7934","key":"hoi230017r21","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41586-022-05165-3","article-title":"Stroke genetics informs drug discovery and risk prediction across ancestries.","volume":"611","author":"Mishra","year":"2022","journal-title":"Nature"},{"issue":"4","key":"hoi230017r22","doi-asserted-by":"publisher","first-page":"None","DOI":"10.1016\/j.xgen.2022.100118","article-title":"Genome-wide risk prediction of common diseases across ancestries in 1 million people.","volume":"2","author":"Mars","year":"2022","journal-title":"Cell Genom"},{"issue":"4","key":"hoi230017r23","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/s41588-021-00783-5","article-title":"The polygenic score catalog as an open database for reproducibility and systematic evaluation.","volume":"53","author":"Lambert","year":"2021","journal-title":"Nat Genet"},{"issue":"7571","key":"hoi230017r24","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A global reference for human genetic variation.","volume":"526","author":"Auton","year":"2015","journal-title":"Nature"},{"issue":"7534","key":"hoi230017r25","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nature13997","article-title":"The African Genome Variation Project shapes medical genetics in Africa.","volume":"517","author":"Gurdasani","year":"2015","journal-title":"Nature"},{"issue":"1","key":"hoi230017r26","article-title":"Development of an electronic health record\u2013based algorithm for smoking status using the Million Veteran Program (MVP) cohort survey response.","volume":"134","author":"Song","year":"2016","journal-title":"Circulation"},{"key":"hoi230017r27","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.2147\/CLEP","article-title":"A phenotyping algorithm to identify acute ischemic stroke accurately from a national biobank: the Million Veteran Program.","volume":"10","author":"Imran","year":"2018","journal-title":"Clin Epidemiol"},{"issue":"12","key":"hoi230017r28","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.1038\/s41596-019-0227-6","article-title":"High-throughput phenotyping with electronic medical record data using a common semi-supervised approach (PheCAP).","volume":"14","author":"Zhang","year":"2019","journal-title":"Nat Protoc"},{"issue":"10","key":"hoi230017r29","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1161\/01.STR.0000032240.28636.BD","article-title":"Validating administrative data in stroke research.","volume":"33","author":"Tirschwell","year":"2002","journal-title":"Stroke"},{"issue":"2","key":"hoi230017r30","doi-asserted-by":"publisher","first-page":"e84","DOI":"10.1016\/S2589-7500(21)00249-1","article-title":"Neural network-based integration of polygenic and clinical information: development and validation of a prediction model for 10-year risk of major adverse cardiac events in the UK Biobank cohort.","volume":"4","author":"Steinfeldt","year":"2022","journal-title":"Lancet Digit Health"},{"issue":"2","key":"hoi230017r31","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/(ISSN)1097-0258","article-title":"Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond.","volume":"27","author":"Pencina","year":"2008","journal-title":"Stat Med"},{"issue":"11","key":"hoi230017r32","doi-asserted-by":"publisher","first-page":"e596","DOI":"10.1161\/CIR.0000000000000678","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines.","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"issue":"24","key":"hoi230017r33","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1056\/NEJMoa1605086","article-title":"Genetic risk, adherence to a healthy lifestyle, and coronary disease.","volume":"375","author":"Khera","year":"2016","journal-title":"N Engl J Med"},{"issue":"8","key":"hoi230017r34","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1161\/CIRCULATIONAHA.121.058426","article-title":"Predictive utility of a validated polygenic risk score for long-term risk of coronary heart disease in young and middle-aged adults.","volume":"146","author":"Khan","year":"2022","journal-title":"Circulation"},{"issue":"9","key":"hoi230017r36","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1056\/NEJMms2004740","article-title":"Hidden in plain sight\u2014reconsidering the use of race correction in clinical algorithms.","volume":"383","author":"Vyas","year":"2020","journal-title":"N Engl J Med"},{"issue":"1","key":"hoi230017r37","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1016\/S2589-7500(21)00236-3","article-title":"Differences in estimates for 10-year risk of cardiovascular disease in Black vs White individuals with identical risk factor profiles using pooled cohort equations: an in silico cohort study.","volume":"4","author":"Vasan","year":"2022","journal-title":"Lancet Digit Health"},{"issue":"21","key":"hoi230017r38","doi-asserted-by":"publisher","first-page":"e393","DOI":"10.1161\/CIR.0000000000000534","article-title":"Cardiovascular health in African Americans: a scientific statement from the American Heart Association.","volume":"136","author":"Carnethon","year":"2017","journal-title":"Circulation"},{"issue":"6590","key":"hoi230017r39","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1126\/science.abm7530","article-title":"Getting genetic ancestry right for science and society.","volume":"376","author":"Lewis","year":"2022","journal-title":"Science"},{"issue":"5","key":"hoi230017r40","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.ajhg.2022.03.007","article-title":"Polygenic transcriptome risk scores for COPD and lung function improve cross-ethnic portability of prediction in the NHLBI TOPMed program.","volume":"109","author":"Hu","year":"2022","journal-title":"Am J Hum Genet"},{"issue":"2","key":"hoi230017r41","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1001\/jamacardio.2022.4466","article-title":"Predictive utility of a coronary artery disease polygenic risk score in primary prevention.","volume":"8","author":"Marston","year":"2023","journal-title":"JAMA Cardiol"},{"issue":"4","key":"hoi230017r42","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/s41591-020-0800-0","article-title":"Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers.","volume":"26","author":"Mars","year":"2020","journal-title":"Nat Med"},{"issue":"8","key":"hoi230017r43","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.jacc.2021.12.016","article-title":"Managing atherosclerotic cardiovascular risk in young adults: JACC state-of-the-art review.","volume":"79","author":"Stone","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"hoi230017r44","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jacc.2022.05.013","article-title":"Polygenic score assessed in young adulthood and onset of subclinical atherosclerosis and coronary heart disease.","volume":"80","author":"Emdin","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"9984","key":"hoi230017r45","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1016\/S0140-6736(14)61730-X","article-title":"Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials.","volume":"385","author":"Mega","year":"2015","journal-title":"Lancet"},{"issue":"22","key":"hoi230017r46","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1161\/CIRCULATIONAHA.116.024436","article-title":"Polygenic risk score identifies subgroup with higher burden of atherosclerosis and greater relative benefit from statin therapy in the primary prevention setting.","volume":"135","author":"Natarajan","year":"2017","journal-title":"Circulation"},{"issue":"5","key":"hoi230017r47","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1002\/cpt.v112.5","article-title":"Polygenic risk score and statin relative risk reduction for primary prevention of myocardial infarction in a real-world population.","volume":"112","author":"Oni-Orisan","year":"2022","journal-title":"Clin Pharmacol Ther"},{"issue":"11","key":"hoi230017r48","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1007\/s00439-022-02452-x","article-title":"The clinical utility of polygenic risk scores in genomic medicine practices: a systematic review.","volume":"141","author":"Kumuthini","year":"2022","journal-title":"Hum Genet"},{"issue":"5","key":"hoi230017r49","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41569-021-00638-w","article-title":"Clinical utility of polygenic risk scores for coronary artery disease.","volume":"19","author":"Klarin","year":"2022","journal-title":"Nat Rev Cardiol"},{"issue":"4","key":"hoi230017r50","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/sim.v34.4","article-title":"Comparing 2 correlated C indices with right-censored survival outcome: a one-shot nonparametric approach.","volume":"34","author":"Kang","year":"2015","journal-title":"Stat Med"},{"issue":"7","key":"hoi230017r51","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1161\/CIRCULATIONAHA.106.672402","article-title":"Use and misuse of the receiver operating characteristic curve in risk prediction.","volume":"115","author":"Cook","year":"2007","journal-title":"Circulation"},{"issue":"9","key":"hoi230017r52","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1002\/sim.5727","article-title":"Testing for improvement in prediction model performance.","volume":"32","author":"Pepe","year":"2013","journal-title":"Stat Med"},{"issue":"4","key":"hoi230017r53","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju041","article-title":"Net risk reclassification P values: valid or misleading?","volume":"106","author":"Pepe","year":"2014","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"hoi230017r54","doi-asserted-by":"publisher","first-page":"122","DOI":"10.7326\/M13-1522","article-title":"Net reclassification improvement: computation, interpretation, and controversies: a literature review and clinician\u2019s guide.","volume":"160","author":"Leening","year":"2014","journal-title":"Ann Intern Med"},{"issue":"8","key":"hoi230017r55","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv157","article-title":"The fundamental difficulty with evaluating the accuracy of biomarkers for guiding treatment.","volume":"107","author":"Janes","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"hoi230017r56","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s41512-019-0064-7","article-title":"A simple, step-by-step guide to interpreting decision curve analysis.","volume":"3","author":"Vickers","year":"2019","journal-title":"Diagn Progn Res"},{"issue":"10","key":"hoi230017r57","doi-asserted-by":"publisher","first-page":"e177","DOI":"10.1016\/j.jacc.2019.03.010","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines.","volume":"74","author":"Arnett","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"hoi230017r8","unstructured":"National Human Genome Research Institute. eMERGE Network. Accessed July 14, 2022. https:\/\/www.genome.gov\/Funded-Programs-Projects\/Electronic-Medical-Records-and-Genomics-Network-eMERGE"},{"key":"hoi230017r18","unstructured":"US Department of Veterans Affairs. Veteran suicide surveillance: methods summary. Accessed March 26, 2023. https:\/\/www.mentalhealth.va.gov\/docs\/data-sheets\/2022\/2022-National-Veteran-Suicide-Prevention-Annual-Report-Methods-Summary-FINAL-508.pdf"},{"key":"hoi230017r19","unstructured":"US Department of Veterans Affairs. VA Privacy Act system of records. Accessed March 26, 2023. https:\/\/www.oprm.va.gov\/docs\/SORN\/Current_SORN_List_02_28_2023.pdf"},{"key":"hoi230017r35","unstructured":"National Human genome Research Institute. Polygenic risk methods in diverse populations (PRIMED) consortium. Accessed March 26, 2023. https:\/\/www.genome.gov\/Funded-Programs-Projects\/PRIMED-Consortium"}],"container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/articlepdf\/2804439\/jamacardiology_vassy_2023_oi_230017_1686936450.81541.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T14:00:50Z","timestamp":1686924050000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/fullarticle\/2804439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,1]]},"references-count":57,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2023.0857","relation":{},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,1]]}}}